Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

epidemiologic * estimate 59

Keyword

Abstract

udy of participants of an seroprevalence study of int
97/Trends in the use of data in HIV prevention corn
ers/The association of risk factors and HIV-1 subt
nfection. in Lima-Peru/ Epidemiological and clinical characteristi
s (BMH1-CT94-1723)/ impact of HIV/AIDS in th
ttendees at New Delhi/ co-relates of HIV infecte
s?/Congenital syphilis: or laboratory diagnosis?
n rates/Work accidents: analysis and seroconver
uary-December 1996/ profile of women over ag
HIV-1 infected women/ and clinical features in 1
da AIDS) in Sao Paulo/ profile of the population
Western Pacific region/ surveillance systems for
ng female adolescents/ features and trends of Al
m 1986 to 1977 (July)/ survey of HIV/AIDS at th
eiro, Brazil/DST/AIDS: profile, spacial distributio
es A and H, found in an epidemiological cluster in Norway/A uniq
nd young adults/The background for new prev
V-infected patients - An and clinical study/Bacilla
DS in Bangladesh - An mystery/HIV/AIDS in Ba
egies for diagnosis and surveillance of HIV infect?/Improving HIV/AIDS surveillance in Liberia: D
V and AIDS in Bahrain/ Epidemiology of HIV and AIDS in Bahrain

24109
43501
60908
12122
13182
13290
22198
23334
23483
23496
33278
43444
43455
60050
60563
11196
13392
42256
43568
60039
60330
13154

/Community sites in the
f cultural reforms in the
ve study in the HAART
idine prophylaxis in the
in AIDS-patients in the
k of CMV disease in the
ssessment study in the
among gay youth in the
um/HIV/AIDS psychoth
dism and wasting in the
potestosteronism in the
d Swiss gay men in the
d to HIV infection in the
edical center during the
demic in Belgium in the
nts without AIDS in the
eeding in the HIV/AIDS
viours/Sexuality in the
-infected patients in the
d adolescents"/In an

- Keyword Abstract
of HIV/AIDS: Butagaya sub-county, Ug 13416
of HIV/AIDS: The case of polygamy in t 14245
/Disseminated Mycobacterium avium c 22168
of combination anti-retroviral therapy/ 22182
of HAART/Predictive value of cytomeg 22241
of protease inhibitors/Risk of CMV dis 22258
of protease inhibitors/AIDS and palliati 22435
of AIDS: A suggestion for a model/The 24110
py in an era of hopefulness, an innovati 24277
of HAART in HIV-infected patients/Hy 32174
of HAART/Hypotestosteronism in the 32275
of new treatments: A comparison of tw 642*/34107
of highly active antiretroviral therapy (H 42412
of heart/Changes in HIV/AIDS pattern 442*/42430
of new treatments/Monitoring the HIV/ 43450
of antiretroviral triple combination thera 43474
in Zimbabwe/Breast feeding in the HIV 313*/44266
of HIV/AIDS in Zambia: Socio-economi 60687
of protease inhibitor therapy/Elderly HI 60704
of constant change, the use of technolo 60922

n an evolving epidemic/
n the US, 1993-1996/
ers in Valencia (Spain)/
elated research issues/
(Vietnam), 1996-1997/
mong indigent patients/
mong women in the HIV
mong women in the HIV
lence in the workplace/
ed patients in Denmark/
et children of Calcutta/
entral Africa/Molecular epidemiology
Uganda/The molecular
South Africa/Molecular
ion in China/Molecular
5-1997/The molecular
with HIV-1 B/Molecular
n Shenzhen/Molecular
Switzerland/Molecular
ustralia/The molecular
/Clinical and molecular
area/A pilot study of the
cal individualism in HIV
ic literature: Trends of"
Switzerland/Molecular
Mozambique/Molecular
cine therapies/On the
uthern Brazil/Molecular

of HIV-1 seroconversion a 518*/13212

of extrapulmonary tubercul
of the children born to HIV-i
of drug abuse-related HIV i
of HPV-infected women in
of HIV infection among indi
Research Study (HERS):
Research Study (HERS) a
of HIV prevalence in the wo
of tuberculosis in HIV-infec
and the problem of STDs le
Sof HIV-1 genetic subtypes i
of HIV-1 in Uganda/The mo
of HIV-1 in KwaZulu-Natal,
of HIV infection in China/M
of HIV-1 infection in the Phil
of HIV-1 in Taiwan: Heteros
analysis of subtype E HIV-1
of HIV-1 in Switzerland/Mol
of long-term asymptomatic
of oropharyngeal candidias
of HIV in a rural area/A pilot
/The questions not asked: T
"and "control and preventio
of HIV-associated tubercul
of HIV-1 in Maputo, Mozam
of slow viruses: New finding
of HIV/AIDS in southern Br

13269
13372
23184
23494
23595
32314
32347
60642
60876
60902
430*/11163
431*/13109
13125
13132
13137
13148
13149
13207
13348
22215
23559
24157
24187
60413
60722
60738
61003

y: Implications for virus eradication /Latent viral reservoirs in patie
ing HAART lead to HIV?/Can durable viral suppressi
e Necessaria alle Cure Erogate in HIV/COMPLIANCE in HIV - C
e service of prevention/ Eroticizing condom use in France: Putting
onship between dental eruption delay and the immunological defi
irus and HIV-viral load/ Erythema of the proximal nailfold in HIV-in
Sequential changes in erythrocyte bound HIV antibody and plas
f genital discharge with Erythromycin tablets, on Yaounde's sexu
acebo-controlled trial of erythromycin versus ciprofloxacin for the t
efficacy of recombinant erythropoietin in AIDS patients with anem
of recombinant human (r-Hu-EPO) in children with
mbolic events and alpha use/A retrospective chart r
ritonavir/Effect of dose escalation on the safety, tolerability and ef
fection/A phase I dose study of 2'-/-fluoro-2',3'-dideo
d transfusion recipient/ Escape recombinants of HIV-1 in a dual-inf
d transfusion recipient/ recombinants of HIV-1 in a dually-i
pplication of a cognitive escape theory to a high-risk drug use and s
Rare occurrence of CTL mutations in HIV-1 infection/Rare
exposed seronegative ( ESN ) partners of HIV-seropositive individu
e "extract spring of life" ( ESOL ) - A report of 65 cases/Treat AIDS a
isease in AIDS/ Esophageal disease in AIDS/
he prevention of STDs especially HIV/AIDS/A multifactorial appr
IV prevention among vulnerable young people (EVY
n HIV/AIDS to villagers, the young female/Giving infor
ampaign/Summer '97, Espiguette beach in southern France: A p
The Five-to-None Trial ( Essai Cinq-a-Zero): Five antiretrovirals co
with heterosexual men: Essential components of a sexuality-base
ork Practices Manual - in the prevention of transmission
valuate the effect of an essential sterol and sterolin formulation as
nuation of training: The component of train the trainer wo
d HIV transmission are to establish standard of care in A
PHI) vs asymptomatic, established infection (AEI)/Immunologica
alysis of Fas/FasL in an -SIV/HIV model in cynomolgu
bodies on the course of infection with HIV-1 primary is
me/Results from newly WOFAK home care and clinic

273*/11150
12188
32386
60466
12167
32268
31102
22209
22189
32141
60150
60894
12283
22281
11183
11199
23113
31125
21124
41238
32119
43166
43244
60026
43175
41194
43318
60244
11236
33364
35*/42201
12193
21167
330*/31103
33356
42136
13420
13442
14101
24363
33260
33593
34353
43154
43217
14328
23548
41163
33264
33397
33459
34169
34290
23548
34182
13299
23490
43482
43487
60197

artners, Venezuela/An epidemological approach to human retro 23561
ussian IVDUs/A recent epidemy of HIV infection in Russian IVDU 13191
oach to follow-up using epiluminescent light microscopy/Kaposi' 22286?/Multiple tuberculosis episodes in HIV infected individuals: Is the 612*/13277
tein (MBP) in infectious in pediatric AIDS/Role of manno 31164
e prophylaxis (PEP) for episodic high-risk sexual behavior by men 576*/33183
optosis of renal tubular epithelial cells involving Fas sensitization 21137
apy/The trophoblastic barrier is not infected in full-term 23286
V transmission through cell barriers/Mechanisms of HIV 278*/32124
ntegrity of the cervical epithelium /Use of the long-acting injectab 23462
ecombination and CTL epitope variation/Cloning of full-length HI 11194
ccine encoding an HIV fused with HBV surface antigen in 11240
ed to a viral-associated /Immunoprecipitation and neutrali 31110
a new virus-associated inducing antibody responsible fort 41111
ng conserved antigenic epitopes shared by HIV-1 virions of differe 11178
moral response to linear of HIV-2 gp36 envelope glycopro 11206
D8+ cytotoxic T cells /A polytope vaccine strategy for t 21193
xic T lymphocyte (CTL) identified in studies of Thai HIV-i 603*/31127
of two overlapping CTL by CTL from a long-term non-pro 31135
cells/Shared antigenic on the V3 loop of HIV-1 gp120 an 32217
carriers of HIV-1/gpl20 of different HIV-1 subtypes/Poly 60824
LV) + Retrovir (ZDV) + Epivir (3TC)/Interim analysis of plasma vir 129*/12219
homa in HIV patients?/ Epstein-Barr virus (EBV) PCR of CSF: Is it 60496
El study/Rhodococcus equi infection in AIDS patients - GESEDA 22111
Is of CTL activity are in equilibrium with viral burden/Control of HI 598*/31130
agement of finance and equipment /Effective and equitable distrib 60018
ase inhibitors/Ensuring equitable access to protease inhibitors/E 42226
quipment/Effective and distribution management of fina 60018
sing whole blood are equivalent to the PBMC-based assay/Cyt 21184
f HIV infections in the era of highly active antiretroviral treatment 12345

nfection among newly
evention interventions: Establishing
ani province, Thailand/
ur surveillance system/
th HIV/AIDS (PLWHA)/
e in the Indian context/
anza Province, Kenya/
a (ANNEA) experience/
ommunity involvement:
e Zambian experience/

Bulgarian seropositives/Adv
trust/Recruiting African-Am
HIV/AIDS programs in the w
an HIV-related risk behaviou
a drop-in-centre with self-hel
counselling intervention with
community based peer educ
an AIDS NGOs network: AID
the criteria/Maintaining com
a national blood transfusion

ural backgrounds when establishing sexuality education program
s of Tondo community/ Establishment-based STD/HIV-IEC Inter
on and cloning of virus/ Establishment of HeLa/CD4-LTR-P-Gal s
gypt/Experience of the establishment of an HIV/AIDS hot-line an
and their impact on the of harm reduction measure
ssons learned from the of an HIV/AIDS hot-line an
organ for collaboration/ of networks on AIDS in Nig
ducive environments to and propagation of self-hel
perating entertainment establishments in depressed areas of To
oholic drinks in drinking, a vulnerable population/
nfection among sugar estate residents in Ethiopia/Effect of HIV i
ence data in California/ Estimate of HIV incidence in women of chil
Iling and testing data to estimate time trends in HIV incidence in S
Mover-Stayer model to the size of the HIV/AIDS epidemi
Mathematical model to the probability of being infected b